Maxcyte, Inc.
Rockville, MD
- UEI
- KM8DZV21HFM8
- CAGE
- 47CG7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9713 Key W Ave #400, Rockville, MD 20850, USA
- Website
- maxcyte.com
- Founded
- 1999
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 26-008363 maxcyte expert GTX electroporation device and installation/operational qualification (IQ/OQ) | Office of Logisitics and Acquisition Operations | $126,250 | |
| 26-003578 maxcyte expert GTX electroporation device and installation/operational qualification (IQ/OQ) | Office of Logisitics and Acquisition Operations | $126,250 | |
| Expert ATX electroporation platform, generation 3 with accessories (region specific power cord) | National Heart Lung and Blood Institute | $55,200 | |
| Maxcyte expert ATX electroporation system | Veterans Integrated Service Network 7 | $49,680 | |
| Expert STX scalable transfection system | National Institute of Allergy and Infectious Diseases | $107,300 |
About Maxcyte, Inc.
Maxcyte, Inc., a Rockville, Maryland-based biotechnology equipment manufacturer, supplies cell electroporation and transfection systems to federal biomedical research institutions as a prime contractor (100% of recent awards) on a full-and-open basis with no set-aside designations. The company manufactures specialized laboratory equipment for cell engineering, gene therapy research, and clinical manufacturing under FDA Current Good Manufacturing Practices, and competes exclusively for sole-source or limited-competition purchase orders rather than on multi-award vehicles.
Maxcyte's customer concentration is heavily skewed toward the National Institutes of Health. The National Institute of Allergy and Infectious Diseases accounts for 10 awards totaling $844 thousand combined potential value — 40% of the vendor's active award count and 44% of its combined potential value. The top five funding entities across both the award-count and potential-value rankings account for 68% and 79% of awards respectively, and together represent primarily DHHS civilian research components: NIAID leads by both measures, followed by the National Heart Lung and Blood Institute ($150 thousand across 3 awards), the Food and Drug Administration ($196 thousand across 2 awards), and the Department of Veterans Affairs, Veterans Health Administration ($215 thousand across 2 awards). Maxcyte serves thirteen distinct federal agencies in total but concentrates its revenue in NIH institutes. The company's primary NAICS profile is Analytical Laboratory Instrument Manufacturing (12 awards), with secondary presence in Research and Development in Biotechnology and Biological Product Manufacturing. Sixteen of 25 awards carry PSC Laboratory Equipment And Supplies.
Recent representative work includes a $126.3 thousand firm fixed-price purchase order from the NIH Clinical Center (awarded March 24, 2026) for a MaxCyte ExPERT GTx Electroporation Device with installation and operational qualification services supporting the Center for Cellular Engineering's cell therapy manufacturing; a $107.3 thousand purchase order from the National Institute of Allergy and Infectious Diseases (July 3, 2024) for an EXPERT STX Scalable Transfection System; and a $55.2 thousand purchase order from the National Heart Lung and Blood Institute (September 26, 2025) for an EXPERT ATX Electroporation Platform, Generation 3, for in vivo gene therapy research. Activity is modest and sporadic — one to two awards per year across the past five years — and the vendor holds no parent contract vehicles, GWACs, or IDIQs. Maxcyte operates exclusively as a prime contractor without subcontract relationships in its federal footprint, delivering equipment and consumables directly to end-user laboratories.
Quick answers
What is Maxcyte, Inc.'s UEI?
Maxcyte, Inc.'s Unique Entity ID (UEI) in SAM.gov is KM8DZV21HFM8.
What is Maxcyte, Inc.'s CAGE code?
Maxcyte, Inc.'s CAGE code is 47CG7.
What is Maxcyte, Inc.'s primary NAICS code?
Maxcyte, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Maxcyte, Inc. located?
Maxcyte, Inc.'s physical address in SAM.gov is 9713 Key W Ave #400, Rockville, MD 20850, USA.
Is Maxcyte, Inc. registered in SAM.gov?
Yes. Maxcyte, Inc.'s SAM.gov registration is active through August 25, 2027.
What is Maxcyte, Inc.'s most recent federal award?
Maxcyte, Inc.'s most recent federal contract award is 26-008363 maxcyte expert GTX electroporation device and installation/operational qualification (IQ/OQ) (75N98026P01361), from Office of Logisitics and Acquisition Operations, on August 19, 2026.
On GovTribe
See Maxcyte, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors